Mark Giaquinto was diagnosed with Parkinson's disease five years ago and continues to combat the illness with a positive ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

A recent survey emphasizes the high prevalence and severity of pain in patients with Parkinson disease. Pain is an important source of distress and disability for patients with Parkinson disease ...

Marc Cohn is walking in his truth. The 65-year-old singer, whose “Walking in Memphis” single took the world by storm in the ...

The manufacturer of AV-101, an investigational, oral nonopioid, NMDA-targeting therapy to treat neuropathic pain, announced that it has received a U.S. patent for the treatment. AV-101 (4-Cl-KYN) is ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

Parkinson's disease is an illness that affects the part of your brain that controls how you move your body. Some people with Parkinson’s first notice weakness, difficulty walking, and stiff ...

Salford Royal Consultant Neurologist and University of Manchester academic Dr Monty Silverdale is to launch the largest ever study of pain in Parkinson’s Disease. The groundbreaking study, to begin ...

Men, more than women, are at risk of developing Parkinson's disease, which is a progressive degenerative disorder of the nervous system that leads to hand tremors. But hand tremors alone cannot ...

New research from McGill University reveals that listening to music at your own rhythm can significantly reduce pain.

Music has the best chance of providing pain relief when it is played at our natural rhythm, a McGill University research team ...